NCT07745075

Brief Summary

Background: Diabetic foot ulcers (DFUs) are severe, chronic complications of diabetes carrying a high risk of amputation. While Negative Pressure Wound Therapy (NPWT) is an active biophysical treatment, clinical evidence using multidimensional tools in Middle Eastern settings like Jordan has been limited. Methods: A 3-month randomized controlled trial (January-May 2026) was conducted at the National Center for Diabetes, Endocrinology, and Genetics (NCDEG) in Amman, Jordan, involving 60 patients with chronic DFUs. Participants were randomized to either an intervention group receiving NPWT (80-125 mmHg, changed every 4 days) or a control group receiving conventional moist dressings (changed every 2 days). Wound trajectories were assessed using the 13-item Bates-Jensen Wound Assessment Tool (BWAT©).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 4, 2026

Completed
Last Updated

August 4, 2026

Status Verified

June 1, 2026

Enrollment Period

4 months

First QC Date

July 24, 2026

Last Update Submit

July 29, 2026

Conditions

Keywords

Negative pressure wound therapy (NPWT)Vacuum-assisted closure (VAC)Diabetic foot ulcer (DFU)Bates-Jensen Wound Assessment Tool (BWAT©)Glycemic control (HbA1c)Wound healing outcomes

Outcome Measures

Primary Outcomes (1)

  • The Bates-Jensen Wound Assessment Tool (BWAT©)

    Formerly known as the Pressure Sore Status Tool (PSST©), the BWAT provides objective, numerical scoring for wound tissue characteristics. It demonstrates high validity and inter-rater reliability (correlation coefficients ranging from 0.80 to 0.90)

    baseline at least 3 mounth post intervention

Study Arms (2)

Control Group

NO INTERVENTION

Patients assigned to the control group received conventional wound dressings applied under standard aseptic protocols on an alternate-day schedule (every 2 days) during their hospital stay.

Intervention Group

EXPERIMENTAL

Following initial surgical debridement in the operating room, a sterile foam dressing was applied to the wound bed under aseptic conditions and secured with an adhesive drape to establish an airtight seal. An evacuation tube embedded within the foam was connected to a vacuum unit, delivering continuous sub-atmospheric negative pressure ranging between 80 and 125 mmHg for 96 hours. Exudate was continuously collected into a sealed canister, transforming open ulcerations into controlled, closed, moist healing environments. Dressings were routinely changed under sterile conditions every 4 days during the inpatient stay.

Other: Vacuum-Assisted Closure (VAC / NPWT)

Interventions

Vacuum-Assisted Closure (VAC / NPWT) Following initial surgical debridement in the operating room, a sterile foam dressing was applied to the wound bed under aseptic conditions and secured with an adhesive drape to establish an airtight seal. An evacuation tube embedded within the foam was connected to a vacuum unit, delivering continuous sub-atmospheric negative pressure ranging between 80 and 125 mmHg for 96 hours. Exudate was continuously collected into a sealed canister, transforming open ulcerations into controlled, closed, moist healing environments. Dressings were routinely changed under sterile conditions every 4 days during the inpatient stay.

Intervention Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older.
  • Diagnosed with superficial chronic diabetic foot ulcers (partial- or full-thickness) located on the plantar surface, metatarsal heads, or sole (Grade 1/clean ulcers). Had a wound length ranging from 10 to 15 cm. Had controlled diabetes mellitus with stable comorbid conditions (e.g., hypertension or non-end-stage renal disease).
  • Were able to speak and read Arabic.
  • Were able to perform activities of daily living (ADLs) independently.
  • Provided voluntary written informed consent to participate in the study

You may not qualify if:

  • Underlying osteomyelitis, Charcot's joint/arthropathy, or DFUs classified as Wagner Grade 3, 4, or 5.
  • Severe peripheral vascular/arterial diseases, venous insufficiency, or bilateral involvement of both feet.
  • Coagulopathic conditions, active bleeding tendencies, or severe immunocompromising diseases.
  • Cognitive or mental impairments preventing informed participation.
  • Severe diabetic complications (e.g., acute cerebrovascular disease).
  • Pregnancy, active fever, or acutely infected wounds at baseline.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the National Center for Diabetes, Endocrinology, and Genetics (NCDEG)

Amman, Dours, 009627, Jordan

Location

Related Publications (1)

  • Abirami, R. S., Bakyalakshmi, S., Swarnalatha, M., Vaishnavi, S. K., & G, V. (2024). A comparative study of standard dressing verses vac therapy dressing in diabetic foot ulcer patients. World Journal of Biology Pharmacy and Health Sciences, 19(3), 620-628. https://doi.org/10.30574/wjbphs.2024.19.3.0620 AlAyed, M. Y., Younes, N., Al-Smady, M., Khader, Y. S., Robert, A. A., & Ajlouni, K. (2017). Prevalence of foot ulcers, foot at risk and associated risk factors among Jordanian diabetics. Current Diabetes Reviews, 13(2), 182-191. https://doi.org/10.2174/1573399812666151210143140 Dharaneesh, S. S., Sridhar, J., Kumar, D., Premnath, P., Kanth, A., & S, S. (2025). Comparison of vacuum-assisted closure (VAC) therapy and conventional dressing on wound healing in diabetic foot ulcer: A randomized controlled trial. Journal of Neonatal Surgery, 14, Article 2087. https://doi.org/10.52783/jns.v14.2087 Mairghani, M., Elmusharaf, K., Patton, D., Burns, J., Eltahir, O., Jassim, G., & Moore, Z. (2017). The prevalence and incidence of diabetic foot ulcers among five countries in the Arab world: A systematic review. Journal of Wound Care, 26(Sup9), S27-S34. https://doi.org/10.12968/jowc.2017.26.sup9.s27 Nirupam, N., & Vinayak, K. (2022). Vacuum-assisted closure vs conventional open treatment in diabetic foot ulcer-A comparative study. Global Journal of Medical Students, 2(3), Article 82. https://doi.org/10.52314/gjms.2022.v2i3.82 Ravisankar, M. S., Sridhar, J., & Babu, D. S. G. (2022). Comparative study of Vac dressing with moist gauze dressing in the treatment of diabetic foot ulcer in tertiary care center. International Journal of Health Sciences, 6(S6), 10387-10395. https://doi.org/10.53730/ijhs.v6ns6.10387 Rodríguez Angulo, A., Caballero-Alvarado, J., Sarmiento-Falen, J., & Zavaleta-Corvera, C. (2025). Comparative assessment of negative pressure wound therapy versus standard treatment in diabetic foot ulcers. Journal of Wound, Ostomy and Continence Nursing, 52(3), Article e1164

    RESULT

Related Links

MeSH Terms

Conditions

Diabetic Foot

Interventions

Negative-Pressure Wound Therapy

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsSurgical Procedures, OperativeWound Closure Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Interventions 6.1 Group A: Vacuum-Assisted Closure (VAC / NPWT) Following initial surgical debridement in the operating room, a sterile foam dressing was applied to the wound bed under aseptic conditions and secured with an adhesive drape to establish an airtight seal. An evacuation tube embedded within the foam was connected to a vacuum unit, delivering continuous sub-atmospheric negative pressure ranging between 80 and 125 mmHg for 96 hours. Exudate was continuously collected into a sealed canister, transforming open ulcerations into controlled, closed, moist healing environments. Dressings were routinely changed under sterile conditions every 4 days during the inpatient stay. 6.2 Group B: Conventional Dressing Patients assigned to the control group received conventional wound dressings applied under standard aseptic protocols on an alternate-day schedule (every 2 days) during their hospital stay. 7\. Outcome Measures and Study Instruments 7.1 Study Instruments Data were gathered us
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof. Dr. Jawad Ahmad Abu-Shennar Assistant Professor of Surgical Diseases Nursing & Diabetes Nursing. Faculty of Nursing, Jerash University, Jerash

Study Record Dates

First Submitted

July 24, 2026

First Posted

August 4, 2026

Study Start

January 1, 2026

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

August 4, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations